Executive Director Tian Lijun reduces his holdings in MEDLIVE (02192) by 240,000 shares at a price of approximately 15.03 Hong Kong dollars per share.
On July 18, Executive Director Tian Lijun reduced his holdings in Medbanks (02192) by 240,000 shares, with each share priced at HK$15.025, totaling HK$3.606 million.
The latest data from the Hong Kong Stock Exchange shows that on July 18, Executive Director Tian Lijun reduced his holdings of MEDLIVE (02192) by 240,000 shares, with a price of 15.025 Hong Kong dollars per share, totaling 3.606 million Hong Kong dollars. After the reduction, the latest number of shares held is 1.3 million shares, with a shareholding ratio of 0.18%.
RECOMMEND
For the Third Consecutive Month, China Reduces U.S. Treasury Holdings by $900 Million in May, While Japan and the United Kingdom Increase Holdings
18/07/2025
Tariff-Driven Inflation Arrives with Delay as U.S. Consumers Begin to Feel the Initial Pinch
18/07/2025
Multiple Countries in High-Stakes Talks with the U.S.; EU Considers Invoking “Anti-Coercion Tool” as U.S. Plans Unified Tariffs on 150 Nations
18/07/2025
